O
Realty Income Corporation
O · Real Estate
Q4 FY2025
Earning ended Dec 31, 2025Report generated Mar 10, 2026
Scale Moat Intact, But the Tenant Reckoning Has Finally Arrived
Most investors misprice this as a rate-sensitivity trade and miss the more important question: the necessity retail thesis depends on tenants staying in business, and two of the defining categories in this portfolio — pharmacy chains and dollar stores — are simultaneously in structural retreat, which means the impairments logged in 2025 are more likely the beginning of a re-underwriting cycle than a one-time event.
Flowly Score
Apr 16 Close
+8%$64.64
Fair Value
$70.00
50
Averageat $64.64
Business Strength6/10
The capital-markets flywheel and triple-net lease model create genuine structural advantages, but the tenant book is quietly deteriorating — pharmacy chains contracting and dollar stores rationalizing simultaneously is a portfolio quality problem that scale alone cannot solve. The 2025 impairments are the bill arriving for years of underwriting against challenged formats.
Financial Resilience5/10
OCF quality is structurally sound and the Piotroski score reflects operational discipline, but an Altman Z sitting below 1.81 — even accounting for typical REIT leverage conventions — and 2025 ROIC turning negative are genuine flags worth watching rather than dismissing as accounting artifacts. The A3 credit rating and 5.4x net debt-to-EBITDA suggest the balance sheet is managed carefully, but there is no margin of safety here; the spread between cost of capital and cap rates does all the work.
Growth & Trajectory5/10
Revenue growth is real but acquisition-manufactured, and the structural EPS dilution from equity issuance is the permanent price of the REIT model — every dollar of growth requires selling shares, and at current prices that arithmetic is merely acceptable rather than compelling. The private capital platform is the single most interesting strategic development, because fee income earned on third-party assets changes the return profile without requiring equity dilution.
Valuation6/10at $64.94
At roughly fifteen-and-a-half times AFFO guidance, this trades at a meaningful discount to its historical range when conditions were more favorable — not deep value, but a real gap to fair value that compensates for modest execution rather than exceptional outcomes. The positive optionality in the private capital platform is not priced in at all, which tilts the asymmetry modestly toward buyers rather than sellers.
Risk4/10
Three risks are converging simultaneously rather than sequentially: Walgreens executing a historic contraction program as a top-five tenant, dollar store operators announcing closures across the portfolio, and a persistently elevated rate environment compressing the acquisition spread that drives per-share AFFO growth. None of these risks individually is existential — the 1,500-plus tenant base absorbs shocks — but their simultaneous arrival tests the resilience thesis in ways the historical record never actually experienced.
The investment case rests on a genuine structural franchise — a capital-markets flywheel built over five decades that lets this business win acquisitions at spreads smaller operators cannot access — trading at a discount to historical AFFO multiples because the rate environment has compressed confidence in the model. That discount is real, the franchise is real, and the monthly dividend covenant with a loyal shareholder base provides a cost-of-equity subsidy that no competitor can replicate without literally waiting half a century. The question is whether current prices already price in sufficient bad news, or whether the tenant deterioration has further to run before stabilizing. The business is heading toward a more complex operating model rather than a simpler one. European exposure now represents nearly a fifth of annualized base rent, the private capital platform is moving from conceptual to operational, and the lease termination and disposition acceleration signals proactive portfolio surgery rather than passive rent collection. If the private capital platform reaches meaningful scale — earning fees on third-party capital rather than deploying its own equity — the return profile improves structurally without requiring dilutive equity raises. That is a genuinely valuable strategic inflection if management executes, and it is receiving almost no valuation credit at current prices. The single biggest specific risk is Walgreens. This is not an abstract tenant credit concern — it is a generational franchise in accelerating structural decline, closing stores at a pace that would have seemed impossible a decade ago, and it sits as a top-five tenant in a portfolio that cannot easily absorb concentrated vacancy. The re-tenanting velocity assumption embedded in current AFFO estimates requires finding replacement tenants for challenged pharmacy real estate in locations that were chosen for their proximity to aging populations rather than their versatility. If Walgreens rationalization accelerates beyond current guidance, the impairment cycle deepens and the re-leasing timeline extends, and those two dynamics compound each other in ways the base case does not adequately reflect.